About Aerocrine
Aerocrine is a publicly listed company based in Solna (Sweden) founded in 1997. Point-of-care devices for airway inflammation measurement are developed. Aerocrine has completed 1 acquisition, including Apieron. Its focus areas include Life Sciences, Pulmonology, Medical Devices and Monitoring Devices.
Company details
Aerocrine was founded in 1997 in Solna, Sweden, focusing on medical devices within the respiratory health sector. Devices such as NIOX VERO are produced to measure nitric oxide levels in exhaled air, aiding assessment of airway inflammation in conditions like asthma. This technology evolved from NIOX MINO, with NIOX VERO introduced in 2014. Acquisition by Circassia occurred in May 2015 for 219 million.
- Headquarters Solna, Sweden
- Stage Public
- SectorsHealthcare
- Website aerocrine.com
- Social LinkedIn Facebook
- Latest Funding Round$363.41K (USD), Grant
Jan 2015
- Investors
- Investments & Acquisitions
Funding Insights of Aerocrine
- Total Rounds 1
- Last Round Grant — $363,414
- First Round $363,414
(Jan 2015)
- Investors Count 1
All 1 funding rounds of Aerocrine with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2015 | $363,414 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Aerocrine
Aerocrine has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Aerocrine
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aerocrine
Aerocrine has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Apieron.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Functions as an asthma monitoring device for health management. | apieron.com | Menlo Park, United States | 2001 | May 2010 | •••• |
Complete acquisition details for Aerocrine
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Aerocrine
3 dated milestones of Aerocrine across 18 years, from founding to its latest funding, stage changes and deals.
- Founded Aerocrine is founded.
- Acquisition Acquires Apieron.
- Funding First funding round of $363K.
Web traffic of Aerocrine
Websites that share an audience with Aerocrine (aerocrine.com).
Websites whose visitors overlap most with Aerocrine. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
jacionline.org | jacionline.org | 100% | #194,118 | – | |
ginasthma.org | ginasthma.org | 96% | #140,283 | – | |
ersjournals.com | ersjournals.com | 69% | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Aerocrine
Aerocrine was founded in 1997 and raised its 1st funding round 18 years after it was founded.
Aerocrine is headquartered in Solna, Sweden.
Aerocrine was founded in 1997 in Solna, Sweden, focusing on medical devices within the respiratory health sector. Devices such as NIOX VERO are produced to measure nitric oxide levels in exhaled air, aiding assessment of airway inflammation in conditions like asthma. This technology evolved from NIOX MINO, with NIOX VERO introduced in 2014. Acquisition by Circassia occurred in May 2015 for 219 million.
Aerocrine has made 1 acquisition, including Apieron.
Aerocrine has 1 investor. Key investors include European Union.